Oncologist Urge FDA to Allow Cancer Patients Access to Silicone Implants, But Continue Study
In Brief: Healy to Name Jay Moskowitz Deputy Direct, Promote Mahoney To Deputy Budge Director
NCI To File Record No. Of INDS In ’92, Expand Phase 1 Trials
Advisors Ok New RFP For Natural Product Large-Scale Production
National Coalition Dinner Honors Cancer Program Founders, Advocates, And Cancer Survivors
DES Exposure Studies Below Payline; NCI Considers Contracts
ICCCR Issues RFP For Cancer Risk Scale
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure - Alec Kimmelman announced as next CEO and Dean of NYU Langone Health
